Non-invasive prenatal screening (NIPS) Non-invasive prenatal screening (NIPS)

Non-invasive prenatal screening (NIPS)

Screen for common genetic conditions and predict your baby's sex as early as 10 weeks

Understand your risk

NIPS is a genetic test that screens for common genetic conditions, like Down syndrome. NIPS works by looking to see if your baby has any extra or missing pieces of genetic material called chromosomes, which may lead to a medical condition. NIPS can also predict your baby’s sex (if you’d like to know). 

NIPS is a screening test, not a diagnostic test

A positive result does not mean your baby definitely has a condition. NIPS is a screening test, which means that it looks to see if your baby has an increased risk, but it cannot diagnose a disorder. Most women who use NIPS discover that their baby’s risk of having a genetic condition is low. Learn more about possible NIPS results.

Video Thumbnail

Everything you need to know about NIPS

NIPS is a simple blood test ordered by your healthcare provider and carries no increased risk of miscarriage. Results are typically available in 5-7 days on average. 

Join certified genetic counselor Melissa Strassberg, M.S., for an in-depth walkthrough of NIPS.

Flexible payment options 


We’ll work directly with your insurance company so you don’t have to. Typically people pay between $0 and $100 out of pocket. Learn more.


Don’t have insurance? We offer $99 pricing and accept HSA/FSA payments. Learn more.

Non-invasive prenatal screening (NIPS)

More than a test: 
Built-in support network 

You don’t have to figure it out alone. Genetics experts are available to guide you through the testing process, help you make sense of your results, and plan a path forward.

Non-invasive prenatal screening (NIPS)

Your questions, answered 

Our resource center offers:

  • answers to common questions about genetic testing 
  • this helpful guide to NIPS
  • details on how the testing process works
  • an explanation of possible results and what they could mean for you

Practice Bulletin No. 163: Screening for fetal aneuploidy. Obstet Gynecol. 2016;127(5):979-81.
Gregg AR, Skotko BG, Benkendorf JL et al. Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics. Genet Med. 2016;18(10):1056-65.